LISTED medical life sciences company Medlab Clinical Limited has launched a wholly owned subsidiary in the EU, with the aim of managing current and future dealings with its NanaBis and proposed drug registration models with the European Medicines Agency (EMA).
The newly incorporated MDC Europe will further the agenda advised during the company's recent annual general meeting, which detailed discussions with the EMA on the pathway for registration of NanaBis.
Conditional approval is likely, but registration with a significant fee reduction requires the company to be domiciled in Europe.
The above article was sent to subscribers in Pharmacy Daily's issue from 05 Dec 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Dec 18
